The global urology robotic surgery market is anticipated to grow at a considerable CAGR of 11.5% during the forecast period. Urology is a medical specialty that focuses on the treatment of the urinary tract and the male reproductive system. Urological conditions can range from relatively minor conditions such as urinary tract infections (UTIs) to more serious conditions such as kidney cancer and others. Urology surgery traditionally involves open surgery or laparoscopic surgery, which involves making small incisions in the abdomen and inserting a camera and surgical instruments. Robotic technology has allowed for the development of minimally invasive urology surgery. In robotic surgery, a surgeon sits at a console and controls a robotic arm, which is equipped with surgical instruments. The robotic arm allows for precise movements, which can be especially important in urology surgery, where the organs and tissues are delicate and sensitive. One of the primary advantages of robotic urology surgery is that it is minimally invasive.
Browse the full report description of “Urology Robotic Surgery Market Size, Share & Trends Analysis Report by Component (Robotic Surgery Systems, Instruments, Accessories, and Services), by Type (Robot Machines, Navigation Systems, Planners, Simulators, and Others), and by Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/urology-robotic-surgery-market
This means that the surgery can be performed through small incisions, which results in less pain, scarring, and a faster recovery time for the patient. It has also allowed for greater surgical precision, which has reduced the risk of complications and improved outcomes for patients. The growing advancement in robotic procedures and launches of innovative robots by key players is driving market growth. For instance, in May 2022, Johnson & Johnson received FDA clearance for its Monarch robotic surgery system, allowing the robot to be used in kidney stone removal procedures. This latest FDA 510(k) clearance for Monarch delivers the company's vision to extend the robotic platform’s capabilities across multiple specialties, enabling hospital systems to target two disease states using one device. With the new urological clearance, doctors will be able to use the surgical robot to snake an endoscope into the kidney to break up and suction out kidney stones, with an attached camera providing a real-time view of the area the whole time.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Component
o By Type
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Accuray Incorporated, Blue Belt Technologies Ltd., CMR Surgical, Intuitive Surgical Inc., Johnson & Johnson, Medtronic Plc, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Urology Robotic Surgery Market Report Segment
By Component
By Type
By Application
Global Urology Robotic Surgery Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/urology-robotic-surgery-market